FDA.reportPublic FDA data

Hemorrhoids

Manufacturer
Hyland's | Standard Homeopathic Company
Effective date
2017-10-16
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 01:11:23

Label at a glance#

ProductHemorrhoids
Active ingredientCALCIUM FLUORIDE, KRAMERIA LAPPACEA ROOT, HORSE CHESTNUT, STRYCHNOS NUX-VOMICA SEED
Label structure8 sections

Indications and uses

Temporarily relieves the symptoms of itching and burning pains, soreness, and swelling due to hemorrhoids.

Dosage and administration

Adults and children 12 years and over: dissolve 2-3 tablets under tongue every 4 hours or as needed. Children 6 years to under 12 years: dissolve 1-2 tablets under tongue every 4 hours or as needed.

Label contents#

Full prescribing information#

OTC - PURPOSE SECTION

Natural relief of itching and burning from hemorrhoids.

Drug Facts

SPL UNCLASSIFIED SECTION

OTC - ACTIVE INGREDIENT SECTION

Active ingredientsPurpose
Aesculus Hippocastanum 6X HPUSsoreness, burning,itching
Calcarea Fluorica 6X HPUSitching

Nux Vomica 6X HPUS

(0.0000016% Alkaloids)

pain, swelling
Ratanhia Peruviana 6X HPUSburning pains, itching

"HPUS" indicates the active ingredients are in the official Homeopathic Pharmacopœia of the United States.

Uses

INDICATIONS & USAGE SECTION

Temporarily relieves the symptoms of itching and burning pains, soreness, and swelling due to hemorrhoids.

WARNINGS SECTION

OTC - ASK DOCTOR SECTION

Stop use and ask a doctor: • bleeding occurs • symptoms persist for more than 7 days or worsen

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

Adults and children 12 years and over: dissolve 2-3 tablets under tongue every 4 hours or as needed.

Children 6 years to under 12 years: dissolve 1-2 tablets under tongue every 4 hours or as needed.

Other information

OTHER SAFETY INFORMATION

  • do not use if imprinted tamper band is broken or missing
  • Hyland's may be contacted for emergency information about our products 24 hours a day, 7 days per week at (800) 624-9659

Drug Facts (continued)

SPL UNCLASSIFIED SECTION

INACTIVE INGREDIENT SECTION

Acacia Gum, Lactose N.F.

Questions or comments?

OTC - QUESTIONS SECTION

(800) 624-9659

PRINCIPAL DISPLAY PANEL-100 TABLET BOTTLE CARTON

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 54973-3207-1

Hyland's®

HOMEOPATHIC

Hemorrhoids

Natural Relief of Itching and

Burning from Hemorrhoids*

100

TABLETS

CartonCarton

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
Data codeCode 12800695002Hemorrhoids_Tablets_Carton.jpg

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
54973-320754973-3207-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Name, UNII, Kind table
NameUNIIKind
CALCIUM FLUORIDEO3B55K4YKIACTIB
KRAMERIA LAPPACEA ROOTP29ZH1A35ZACTIB
HORSE CHESTNUT3C18L6RJAZACTIB
ACACIA5C5403N26OIACT
LACTOSE MONOHYDRATEEWQ57Q8I5XIACT
STRYCHNOS NUX-VOMICA SEED269XH13919ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
4f87b438-de5c-b8d6-e063-6294a90a9f7a5bad7327-044e-297e-e053-2a91aa0a0a042026-04-15WarningsExact identifier
spl set id: 5bad7327-044e-297e-e053-2a91aa0a0a04

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.